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Autoimmunity to Pancreatic Juice in Crohn's Disease 
Results of an Autoantibody Screening in Patients with Chronic 
Inflammatory Bowel Disease 
W. S T Ö C K E R , M . O T T E , S. U L R I C H , D . N O R M A N N , H . F I N K B E I N E R . 
K. S T Ö C K E R , G. J A N T S C H E K & P. C. SCRIBA 
Dept. of Medicine and Dept. of Psychosomatic and Psychotherapy, 
Medical University of Lüheck , Lübeck , FRG 
Stöcker W, Otte M , Ulrich S, Normann D , Finkbeiner FI. Stöcker K, Jantschek G . 
Scriba PC. Autoimmunity to pancreatic juice in Crohn's disease. Results of an 
autoantibody screening in patients with chronic inflammatory bowel disease. Scand 
J Gastroenterol 1987, 22 (suppl 139), 41-52 
The sera of 59 patients with Crohn's disease (CD) and of 46 patients with ulcerative 
colitis (UC) were tested for autoantibodies (Aab) by indirect immunofluorescence 
with modern histochemical techniques using 19 different human tissues as antigenic 
substrates. Control collectives consisted of 19 patients with coeliac disease and of 
100 healthy subjects. It was possible to demonstrate a specific marker for C D : Aab 
against exocrine pancreas (Pab) were present in 39% of the CD sera (UC 4%, coeliac 
disease 0%, healthy controls 3%). High Pab titres were only detectable in CD sera 
(29%). The CD-related autoantigen was demonstrated to be a component of normal 
pancreatic juice. Pab in CD were fundamentally different from those sometimes 
occurring in chronic and acute pancreatitis. It is suggested that C D is caused by 
autoimmune reactions against a component of pancreatic juice. Pab in CD correspond 
to Aab against intestinal goblet cells (Gab), which occurred exclusively in UC (28%). 
Pab and Gab, but obviously none of the other Aab investigated in this study, are of 
diagnostic value in chronic inflammatory bowel disease. 
Key words: Autoantibodies; autoimmunity; chronic inflammatory bowel disease; 
coeliac disease; Crohn's disease, aetiology; Crohn's disease, serodiagnosis: flu-
orescent antibody techniques; pancreatic autoantigens; pancreatitis; ulcerative colitis, 
serodiagnosis 
Dr. med. W. Stöcker, Klinik für Innere Medizin, Medizinische Universität, Rat-
zeburger Allee 160, D-2400 Lübeck, FRG 
In chronic inflammatory bowel disease ( C I B D ) , 
a number of observations support the concept of 
an autoimmune aetiology. Remarkably, in the 
sera of some patients with ulcerative colitis (UC) 
autc antibodies (Aab) can be observed which 
react with antigens of intestinal goblet cells. These 
antibodies were first demonstrated by means of 
hemagglutination and gel diffusion methods (1) 
and later by indirect immunofluorescence (2-10). 
S.nce in C I B D primarily the bowel is 
concerned, studies were usually restricted to Aab 
against intestinal tissue. Despite the frequently 
occirring extraintestinal manifestations of 
Crohn's disease (CD) , only very few studies have 
dealt with the prevalence of Aab directed against 
other than bowel antigens in C I B D , and the 
number of Aab tested were limited (8, 11-13). To 
obtain a comprehensive overview on Aab in 
C I B D , Aab profiles were established in sera from 
patients with CD and UC. Patients with coeliac 
disease, as well as healthy subjects without evi-
dence of bowel disease, served for control. 
As reported earlier (10), in these experiments 
the occurrence of Aab to intestinal goblet cells 
(Gab) in UC could be confirmed. Beyond this, 
it was possible to demonstrate CD-specific Aab 
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against an antigen of the exocrine pancreas 
(Pab). In the present paper, the results of the 
Aab screening are summarized and further data 
are provided to evaluate the significance of the 
established CD-specific autoimmunity. 
M A T E R I A L S A N D M E T H O D S 
Subjects 
Serum samples were obtained from patients 
with Crohn's disease (n = 59), ulcerative colitis 
(n = 46), coeliac disease (n = 19), and healthy 
subjects (n = 100). Diagnoses of the patients were 
established by clinical examination and, in each 
instance, confirmed both by endoscopy and 
histology. 
Patients with Crohn s disease (CD). This group 
includes 22 men (average age, 26.0 years) and 37 
women (average age, 28.4 years). A t time of 
blood drawing, 49 patients with CD received sali-
cylazosulfapyridin, 43 patients of them were 
treated additionally with corticosteroids. Disease 
activity was estimated according to Best et al. (14; 
CD A I ) . In 14 of the CD patients symptoms were 
recorded which can be regarded as extraintestinal 
manifestations of the disease. None of the patients 
with CD had clinically apparent chronic or acute 
pancreatitis. 
Patients with ulcerative colitis (UC). Of 46 
patients with UC, 23 men (average age, 40.3 
years) and 23 women (average age, 34.5 years), 
40 had been treated with salicylazosulfapyridin, 
30 also with corticosteroids. The current activity 
of UC was assessed using a modified C D A I . 
Control subjects. Collectives of 19 patients with 
coeliac disease (6 men, average age 52.2 years, 
and 13 women, average age 54.8 years) and of 
100 healthy volunteers (62 men; average age, 34.3 
years; and 38 women; average age. 28.6 years) 
served for control. 
Blood was drawn from all subjects for deter-
mination of autoantibody profiles by indirect 
immunofluorescence. Sera were separated and 
stored at - 8 0 °C for up to 2 years before testing. 
Screening for autoantibodies 
Aab were determined by indirect immuno-
fluorescence, employing a broad panel of tissues 
(blood group O) as antigenic substrates which 
included human adult pancreas, parotis, liver, 
lung, striated and smooth muscle, heart, thyroid 
(unfixed sections plus methanol-fixed sections), 
parathyroid, adrenal, ovary, placenta, testis, 
hypophysis, kidney, and sterile human fetal 
esophagus, stomach, duodenum, ileum, and 
colon. Normal adult human tissue was obtained 
at surgery, fetal tissue from a still-born infant at 
32 weeks' gestation. Organs were snap-frozen in 
melting isopentane and stored up to 3 years at 
- 1 9 6 ° C . 
The test procedure was facilitated by new rapid 
and economic microtechniques described earlier 
(15, 16). In brief, 4-//m tissue sections were cut 
with a Leitz-1720 cryotome (Leitz. Wetzlar, 
ERG) at - 2 2 °C. Sections were applied to chemi-
cally activated glass cover slides, thawed, and 
dried. The cover slides were cut with a glazier's 
diamond, and broken into pieces (fragmenting 
technique). Chemical activation (17) was per-
formed, to enable covalent coupling of the tissue 
sections to the glass surface, thus effectively 
improving the adhesion of the sections. 
Section fragments, carrying relevant organ 
structures, were sealed in blisters and stored in 
liquid nitrogen until use. They were glued on 
reaction areas of a glass plate (sections" support), 
samples or fluorescein-labelled antisera were pip-
etted on hydrophilic reaction areas of another, 
plane, glass plate (reagents' support). The reac-
tion areas were surrounded by a hydrophobic 
coating, which prevented mixing of neighbouring 
samples. The sections' support was laid above the 
reagents' support in such a way that the tissue 
sections were immersed in the liquid (titerplane 
technique). 
Aab screening was performed by a composite-
section technique. Section fragments of 19 dif-
ferent tissues were glued side by side on large 
reaction areas and co-incubated in the same drop 
of sample or reagent (200//l per 19 sections). The 
single-section technique was used to determine 
the immunoglobulin classes of established Aab. 
to identify their ability to fix complement, anc to 
determine Aab concentrations by titration: Sec-
tion fragments were glued on small reaction areas 
and incubated in droplets of 10 ul, each section 
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fragment being immersed individually in a single 
droplet of the liquids. 
immunoflnoreseence staining 
Composite sections were incubated for 60 min 
w ith sera which were usually diluted 1: 10 ih pho-
sphate-buffered saline. Sections were stained for 
a further 60 minutes with a polyvalent fluorescein-
conjugated rabbit antihuman immunoglobulin, 
directed against IgA + IgG + I g M + kappa + 
lambda ( D A K O , Hamburg, FRG). The sections 
were washed for 60 min after each stage in three 
changes of phosphate-buffered saline, with 
gentle agitation. Positive sera were titrated in 
steps of 1:32, 1:100, 1:320, etc., using single 
sections. 
Heavy- and light-chain specificities of Pab and 
Gab were determined using monospecific fiuor-
escein-conjugated rabbit antihuman IgA, IgD, 
IgE, IgG, I g M , kappa and lambda 
(Behringwerke, Marburg, FRG) , instead of the 
polyvalent antiserum. 
Each serum sample was tested for complement-
fixing Pab and Gab by a three-layer indirect 
immunofluorescent test. The first layer was com-
posed of 1:10 diluted patient's serum (incubation 
at room temperature for 1 h), the second of undi-
luted normal human serum (blood group A B ) 
as complement source (1 h), the third contained 
fluorescein-conjugated rabbit antihuman C l q , 
C3c\ or C4 (1 h; Behringwerke). Essential con-
trols in each serum included staining with FITC-
conjugated rabbit antihuman globulin directed 
against albumin. 
Mieroscop:c examination 
Results were read subjectively with a Leitz 
Dialux-20 microscope by two individuals, inde-
pendently of each other, without knowledge of 
the patients1 diagnoses. The microscope was fitted 
with epi-illumination, 50-W HB-50 mercury lamp, 
filter combination J 2, mirror RKP510, mag-
nification x250 (Leitz, Wetzlar, FRG). A l l results 
were read double-blind with positive and negative 
control sera in each batch. 
Neutralization tests 
The CD-related autoantigen was detected by a 
Pab neutralization technique (18): Diluted Pab-
containing CD sera were incubated for one hour 
with equal volumes of different diluted organ 
homogenates or different liquids: 
Supernatants of homogenized human liver, 
heart, pancreas (homogenization was accom-
plished by producing 5-j.im-thick frozen sections 
with the cryotome; to the slices nine volumes of 
buffered saline were added); 
Human duodenal juice; 
Human pancreatic juice (collected by endo-
scopic cannulation of the main pancreatic duct); 
Fluids of pancreatic pseudocysts (obtained 
from patients with chronic pancreatitis for diag-
nostic purposes); or 
FPLC column effluents (fast protein liquid 
chromatography). 
After incubation, titres of free Pab in the mix-
tures were determined by the indirect fluorescent 
antibody test using frozen sections of human adult 
pancreas, as described above. The capacity of 
these substances to extinguish specific immuno-
fluorescence was recorded. 
Ch ro m a tograp hy 
Human pancreatic juice and fluids of pancreatic 
pseudocysts were analyzed by gel filtration 
chromatography FPLC (Superose 6, Pharmacia 
Fine Chemicals, Freiburg, FRG). The antigen-
containing fractions were identified by monitoring 




The prevalence of 22 different autoantibodies 
(Aab) was determined in Crohn's disease (CD) 
and in ulcerative colitis (UC) , as well as in the 
control collectives, which consisted of patients 
with coeliac disease and of healthy persons. 
In C D , Aab against exocrine pancreas (Pab) 
turned out to be very frequent, and they oc-
curred in high concentrations (Figs. 1 and 2). 
The Aab screening confirmed the prevalence of 
Aab against intestinal goblet cells (Gab) in U C 
(Fig. 3). 
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Figs. 1 and 2. Autoantibodies against exocrine pancreas in Crohn's disease. Deter-
mination by indirect immunofluorescence. Unfixed frozen sections of human adult 
pancreas were incubated in the first step with 1:10 diluted sera of patients with 
C D , in the second step with a polyvalent fluorescein-conjugated rabbit antihuman 
immunoglobulin. Fig. 1 {top). Serum of CD patient 22; reticulogranular pattern. 
Fig. 2 (bottom). Serum of CD patient 27; droplet-like pattern. 
Results of the Aab screening are summarized 
in Table I . In addition to Pab and Gab, in patients 
with CD and U C the following Aab occurred with 
a higher frequency than in coeliac disease and in 
healthy subjects: Aab to gastric mucosa (pref-
erence to CD) , Aab to 'single cells1 of connective 
tissue and to cell nuclei (preference to UC) , and 
Aab to enterocytes and nerve tissue (elevated in 
both). None of these Aab correlated with Pab 
and Gab. Their bearing on the pathogenesis of 
C I B D is not yet understood. 
Aab to the other tissues employed in this study 
have not been more frequent in C I B D than in 
healthy control subjects. 
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Fig. 3. Autoantibodies against intestinal goblet cells in ulcerative colitis. Deter-
mination by indirect immunofluorescence. A n unfixed frozen section of human fetal 
duodenum was incubated in the first step with the 1: 10 diluted serum of UC patient 
38, in the second step with a polyvalent fluorescein-conjugated rabbit anti-human 
immunoglobulin. 
Autoantibodies to exocrine pancreas (Pab) 
Aab to the exocrine pancreas (Figs. 1 and 2) 
were discernible by a striking reticulogranular 
fluorescence in the cytoplasm of the pancreatic 
acinar cells, with an increasing intensity in the 
direction of the acinar centre. With the most 
positive sera fluorescent droplets became visible 
in the centre of the acini. Pancreatic islets were 
not stained by Pab. 
Pab could be observed in 23 out of 59 patients 
with Crohn's disease (39%). In 17 patients (29%) 
the litre of Pab was 1 :100 or higher. Such high 
concentrations have been found neither in UC, 
nor in coeliac disease and healthy controls. 
Six of the 23 Pab fixed complement. In these 
cases, the C D A I was twice as high (225.3 ± 139.4) 
than in 17 patients with non-complement-fixing 
Pab (99.7 ± 85.2). 
In patients whose CD had been present for 
less than 2.5 years the prevalence of Pab was 
determined as being only 25%. I f CD existed 
longer than 2.5 years, patients exhibited Pab in 
46%. In CD patients having extraintestinal mani-
festations of the disease, the prevalence of Pab 
was 50%, in patients without extraintestinal mani-
festations only 33%. 
The prevalence of Pab was dependent neither 
on sex, old age or blood group ( A , B, A B , O) of 
the patients, nor on the intestinal localization of 
the disease or on a therapy with salicyla-
zosulfapyridin. Corticosteroids seemed to reduce 
the prevalence of Pab (15 of 43 patients = 35%), 
patients without corticosteroids showed Pab in 8 
of 16 cases (50%). 
Pab were also found in 2 out of 46 patients with 
the diagnosis of U C (4%; titres 1: 10 and 1:32). 
Three sera of 100 control subjects exhibited Pab 
in titres of 1:10. 
Autoantibodies to intestinal goblet cells (Gab) 
Autoantibodies to intestinal goblet cells (Gab) 
(Fig. 3) were a distinguishing mark of UC. Gab 
were discernible in the epithelium of the mucosa 
as hazy confined, cloudy spots. They could be 
detected with each segment of the bowel used as 
antigenic substrate from duodenum to the rectum. 
But positive and negative staining could be distin-
guished better with small intestine than with 
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Table I . Autoantibody profiles in Crohn's disease, ulcerative colitis, coeliac disease, and healthv subjects 
Prevalence of clinically significant Aab titres 
Prevalence (%) of 
autoantibodies to 
Crohn's disease 
(/i = 59) 
Ulcerative colitis 
(// = 46) 
Coeliac disease 
(n - 19) 
Healthv con t ro l 
(ti = 100) 
Exocrine pancreas (Pab), 
titre 1:100-1:1000 
Exocrine pancreas (Pab), 
titre 1:10-1 : 1000 
Intestinal goblet cells (Gab), 
titre 1 : H M : 1000 
Gastric mucosa, 
(granular pattern) 



































The Aab screening was carried out employing the following human tissues as antigenic substrates: Adul t 
pancreas, parotis, liver, lung, striated and smooth muscle, heart, thyroid, parathyroid, adrenal, ovary, placenta, 
testis, hypophysis, kidney, and sterile human fetal esophagus, stomach, duodenum, ileum, and colon. In addition 
to the Aab listed in the table, the control group exhibited Aab to thyroglobulin ( 5 % ) , striated muscle ( 1 % ) , and 
pancreatic islets (1%) . Further Aab were not detectable in any of the four groups. 
colon, since in the small intestine goblet cells are 
separated from each other and in the colon goblet 
cells appear as a coalescing cloudy mass. 
Gab were present in 13 of 46 patients with UC 
(28%), but in no case of CD and coeliac disease 
and in none of the healthy control persons. Serum 
concentrations varied from patient to patient, 
titres were determined between 1:10 and 1:1000. 
The (UC-adapted) activity index in patients 
with Gab was 136 ( ± 9 3 ) . In patients without Gab, 
disease activity was 85 ( ± 7 5 ) . 
None of the established Gab fixed complement. 
The occurrence of Gab correlated neither with 
the patients' old age, nor with the duration of the 
disease or the therapy. 
A preponderance of Gab was observed in 
males: Gab occurred in 10 of 23 male UC patients 
(43%), but only in 3 out of 23 female patients 
(13%). Additionally, the distribution of Gab in 
patients with different blood groups was not even: 
In blood group A the prevalence was 38% (6 of 
16), in group B 40% (2 of 5), in group A B 66% 
(2 of 3), in group O only 16% (3 of 19). 
Immunoglobulin classes of Pab and Gab 
Pab mainly belonged to IgG and Ig A , one 
patient exhibited IgD and one patient I g M . Pab 
of class IgE were not observed (Table I I ) . 
In Gab, only immunoglobulin classes IgA and 
IgG could be observed (Table I I ) . IgM were not 
detected. 
Light chains of Pab and Gab 
To find out whether Pab and Gab were of 
oligoclonal or of polyclonal origin, their light 
chains were analyzed by indirect immuno-
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Table I I . Immunoglobulin classes of Pab and Gab, and their ability to bind complement factor C3c. Pab contained 
i n two cases additionally IgD, but never IgE. Gab consisted exclusively of IgA and/or IgG 
Reaction 
dotal IgA alone IgG alone IgA + IgG IgM alone with C3c 
Pab in CD 23 2 8 12 1 6 
Gab in UC 13 1 3 9 0 0 
fluorescence: kappa and lambda were evenly 
distributed in 11 of 23 Pab; in 7 cases kappa over-
balanced lambda, and in 5 cases lambda over-
balanced kappa (Table I I I ) . Similar data were 
obtained in Gab: kappa was equal to lambda in 
^ of 13 cases, kappa predominated in 3 cases, and 
lambda in 1 case. 
Other au to antib odies 
Aab to gastric mucosa gave a granular staining 
in single, up to now not identified cells of the 
gastric glands. They were present in only very low 
concentrations (to detect these Aab, the patients' 
sera had to be used undiluted in the first step of 
the indirect fluorescent antibody test). Of the CD 
patients 4 1 % exhibited this antibody (UC. 11%; 
coeliac disease. 5% ; healthy controls, 6%), which 
correlated neither with Pab nor with parietal cell 
antibodies. 
Aab to 'single cells' of connective tissue: In the 
sera of some patients with UC an Aab was found 
which reacted with the cytoplasm of large, spor-
adically distributed cells in the connective tissue 
Table I I I . Reactions of Pab and Gab with fluorescein-
labelled anti-kappa or anti-lambda. Titre 1:3.2 and 
1:10 - + ; 1 :32 and 1 : 100 = + + ; ! : 320 and 1 : 1000 = 
+ + + 
Lambda 
Kappa 0 + + + + + + 
Antibodies to exocrine 0 0 0 
pancreas in C D + 4 7 -) 0 
(23 positive sera) + + 1 1 1 
+ + + 0 0 0 3 
Antibodies to intestinal 0 0 1 0 
goblet cells in UC -r ~> 9 0 0 
(13 positive sera) + - f 0 0 0 0 
+ + + 1 0 0 0 
of nearly every organ including pancreas, liver, 
kidney, and thyroid. The target cells have not yet 
been identified. Serum titres between 1:10 and 
1:320 were observed (UC, 17% ; CD, 2% ; coeliac 
disease, 0%; controls, 0%). Clinical symptoms 
could not be detected, which would explain the 
implication of these Aab. 
Significant concentrations of Aab to cell nuclei 
(titre 1:100 or higher) have been stated with 
a significantly higher frequency than in control 
subjects in UC and with a lower extent in CD 
(UC 26%; CD, 8% ; coeliac disease, 5% ; healthy 
controls, 6% ). 
Aab to enterocytes were common in both CD 
(39% ) and UC (33% ), but also in coeliac disease 
(10% ) and in healthy controls (14%; Table I ) . 
They reacted with the cytoplasm of the entire 
population of intestinal epithelial cells including 
the goblet cells. These Aab exhibited the same 
affinity to each of the different bowel segments. 
Aab to enterocytes were different from Pab and 
Gab, they occurred independently from these 
Aab in CD and UC. 
Aab to nerve tissue reacted with nerves and 
with the cytoplasm of plexus cells in many 
organs. They were especially well discernible with 
human fetal tissue of the gastrointestinal tract 
(plexus Auerbachi et Meissneri). Their preva-
lence in CD was 22% and in UC 26% (coeliac 
disease, 5%; healthy controls, 2%). 
Detection of the CD-related autoantigen in pan-
creatic juice 
Neutralization experiments have been per-
formed with different pancreas-derived sub-
stances to evaluate the possible role of the 
exocrine pancreas in the pathogenesis of CD. 
The neutralizing efficacy of crude duodenal 
juice or homogenized pancreas could not be 
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Table I V . Neutralization of autoantibodies with different pancreas-derived substances, whose capacity to extinguish 
specific immunofluorescence was estimated by titration. Liquids were used undiluted; supernatants of organ 
homogenates were diluted 1 : 10 in phosphate-buffered saline. In the table, the reciprocal titres are listed 
Neutralization of autoantibodies with 
Phosphate- Cystic Cystic Column 
( T i t r e ) - 1 of buffered fluid fluid Pancreatic effluent Parotic Homog. Homog. 
autoantibodies to saline 1 2 juice fract. 14 saliva liver heart 
Exocrine pancreas 
(serum 11) 100 3.2 100 3.2 10 100 100 100 
Exocrine pancreas 
(serum 13) 1000 32 1000 10 32 1000 1000 1000 
Pancreatic 
islet cells 100 100 100 100 100 100 100 100 
Intestinal 
goblet cells 320 320 320 320 320 320 320 320 
Cell nuclei 1000 1000 1000 1000 1000 1000 10 100 
Mitochondria 1000 1000 1000 1000 1000 1000 100 3.2 
evaluated. Their inherent proteinases became 
activated and digested the tissue sections, thus it 
was not possible to interpret the results of the 
fluorescent antibody test. 
Well-interpretable results were obtained, how-
ever, when pancreatic juice or fluids of pancreatic 
pseudocysts were used for neutralization. In both 
cases positive Pab reactions were abolished or 
titres were reduced by at least 4 double dilution 
steps in each of the 23 Pab-positive sera studied. 
In contrast, pancreatic juice and fluids of pan-
creatic pseudocysts did not neutralize auto-
antibodies against cell nuclei, mitochondria, 
smooth muscle, gastric parietal cells, intestinal 
goblet cells, thyroid microsomes, and pancreatic 
islets (Table I V ) . 
Separation of the CD-related autoantigen: The 
hypothetical CD-related autoantigen was con-
tained in one single peak and behaved chro-
matographically as a macromolecule of about 106 
dalton. It was different from functionally active 
amylase, lipase, trypsin, and chymotrypsin, which 
were identified by biochemical standard pro-
cedures in separate peaks (18). 
W i t h the pancreatic autoantigen containing 
fraction, each of the positive Pab reactions in the 
23 C D sera studied could be abolished in the 
neutralization experiments. Thus, the antigenic 
specificity of Pab seems to be uniform. 
DISCUSSION 
Autoantibody profiles were established in chronic 
inflammatory bowel disease ( C I B D ) by indirect 
immunofluorescence with modern histochemical 
techniques. Results of this study confirm that 
significant autoimmune reactions do exist in 
C I B D . In Crohn's disease (CD) as well as in 
ulcerative colitis (UC) , disease-specific Aab could 
be demonstrated, which were directed against 
exocrine pancreas in CD (10, 19) and against 
intestinal goblet cells in UC. With regard to serum 
concentration and disease specificity, Pab and 
Gab were as conspicuous as other autoantibodies 
in proven autoimmune diseases. 
A number of further Aab were found which 
occurred in C I B D with a higher frequency than 
in control collectives, but were of less significance 
than Pab and Gab: Aab to enterocytes and to cell 
nuclei (neither specific for C D nor for U C ) , Aab 
to gastric mucosa (occurred in very low con-
centrations), and Aab to 'single cells1 of con-
nective tissue (low prevalence). The other Aab 
determined in this study were as rare in C I B D as 
in healthy persons and in patients with coeliac 
disease. 
The results made evident that Crohn's disease 
is associated with potent autoimmune reactions 
against pancreatic juice: In C D , autoantibodies to 
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exocrine pancreas were frequent and they usually 
occurred in considerably high concentrations in 
thie patients' sera. High titres of Pab could be 
recorded neither in patients with U C or coeliac 
di:sease nor in healthy subjects. 
In rare cases of chronic and acute pancreatitis 
A a b can be found, which also react with acinar 
cedls of the pancreas (20-22). One may ask 
whether there exist immunological differences 
between the two conditions. Hellwig et al. (22) 
have characterized serum Aab against exocrine 
pancreas in pancreatitis: The prevalence of 
significant concentrations was as low as 6.5% in 
chronic and acute pancreatitis (5 of 77 cases) and, 
if these antibodies were present, titres did not 
exceed 1:32. Pab in pancreatitis consisted only of 
I g A , did not fix complement and could not be 
neutralized by the CD-related autoantigen (Table 
V ) . On the other hand, Pab were frequent in 
C D , they usually occurred in high concentrations, 
contained IgG in most cases, sometimes fixed 
complement and could be neutralized by the CD-
related autoantigen in each case. Thus, Pab in 
pancreatitis differed fundamentally from those in 
C D . 
In patients with pancreatitis it is conceivable 
that antigens released from the injured pancreas 
induce a secondary immunization without impor-
tant pathogenetical implications. If pancreatic 
immunity were also an epiphenomenon in C D , 
immunoreactions should be of comparable 
dimensions. But in C D , humoral immunity 
against exocrine pancreas exceeds by far that 
found in pancreatitis, thus it is suggested that 
autoimmunity to pancreatic antigens is essential 
in CD. 
The CD-related autoantigens were distributed 
like secretory proteins in the exocrine pancreas, 
as could be observed in the indirect fluorescent 
antibody test. Are these antigens secreted into 
the bowel lumen? In this study it was documented 
by neutralization experiments that the CD-related 
autoantigens really are contained in normal pan-
creatic juice. Therefore, it is imaginable that the 
exocrine pancreas is implicated in the patho-
genesis of CD: 
Crohn's disease may be caused by autoimmune 
reactions against the exocrine pancreas. The 
bowel has developed a state of hypersensitivity 
against a component of pancreatic juice. The 
autoantigens are synthesized in the pancreas and 
secreted into the bowel. In the bowel wall they 
react with locally present autoantibodies and form 
immunocomplexes which induce activation of 
complement and inflammation. It is also con-
ceivable that the autoantigens bind unspecifically 
to tissue structures and transform them to targets 
of immunoattacks. 
The in vitro observed autoimmunity to pan-
creatic juice in CD corresponds to a number of 
histological, clinical, and epidemiological 
phenomena: 
A striking augmentation of plasma cells in the 
intestinal CD lesions (23,24) reflects a response 
to hitherto unknown antigens. 
Diversion of the fecal stream by an ileo- or 
colostoma usually results in an immediate clinical 
improvement of acute Crohn colitis. In U C , this 
Table V . Characteristics of autoantibodies to exocrine pancreas in CD and in pancreatitis 
Crohn's disease Acute and chronic pancreatitis 
Prevalence of Pab 39% 5% 
Concentration of Pab Usually high (titre 1:100 or higher Low (titre max. 1:10) 
in 3 of 4 positive cases) 
Immunoglobulin class Usually IgG IgA only 
of Pab or IgG plus IgA 
Complement fixation Sometimes observed Not observed 
of Pab 
Pab neutralize the In all cases observed Not observed 
CD-related autoantigen 
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treatment is without positive effects (25). Fur-
thermore, an intestinal lavage with physiologic 
saline reduces the activity of the disease. This 
indicates that toxic (antigenic?) substances are 
contained in the bowel lumen (26). 
The beneficial effect in CD of parenteral 
nutrition (27) or a low-fat elemental diet (28, 29), 
which reduce pancreatic secretion to levels near 
those observed during fasting (30-33), might also 
indicate an impaired tolerance to pancreatic juice 
in C D . 
Patients suffering from CD develop a pre-
dilection for refined sugar. They consume sig-
nificantly more carbohydrates than UC patients 
and healthy control persons (34—37). This has 
been considered to be a causative factor in CD, 
but another interpretation seems also to be con-
ceivable: sugar and starch do not stimulate protein 
synthesis in the exocrine pancreas, and glucose 
even inhibits the secretin/pancreocymin-stimu-
lated pancreatic secretion (38, 39). Patients with 
CD unconsciously realize the reduced tolerance 
to pancreatic juice, and they try to minimize the 
pancreatic-juice-mediated injury to the bowel. 
The increasing incidence of CD in wealthy 
countries might be attributed to the nutrition, 
which is rich in protein and fat. The over-con-
sumption of food leads to a strong and long-
lasting stimulation of the exocrine pancreas. The 
gut-associated immune system comes perma-
nently into contact with large amounts of the 
(hypothetical) autoantigen, and predestinated 
subjects develop autoimmune reactions to pan-
creatic juice and CD. 
Extraintestinal manifestations in many patients 
with C D might be caused by deposition of cir-
culating immunocomplexes (consisting of Pab and 
the corresponding autoantigen) or by immuno-
reactions against the CD-related autoantigen 
which are contained in the affected tissues and 
presented to the immunosystem more effectively 
than in the pancreas. In spite of the established 
pancreatic immunity, pancreatitis is not pre-
dominant in CD since the bulk of autoantigens 
comes into contact with the immune system only 
outside of the pancreas. 
The autoimmunity against exocrine pancreas in 
CD is a counterpart to autoimmune phenomena 
in UC. Aab against intestinal goblet cells in U'C 
are well established and may have a p a t h o 
genetical implication since Gab are specific fo r 
UC and goblet cells show macroscopically anid 
microscopically the same localization as thie 
disease: They are rare in the small intestine, buit 
arranged closely side by side in the colon, increas-
ing in the direction to the rectum. Furthermore, 
the number of goblet cells is the highest in tine 
crypts. Accordingly, in UC, the small intestine is 
not affected, but the rectum nearly in each cas»e, 
and cryptitis is a typical feature of UC. 
Instead of adult tissue, fetal intestine was 
employed as antigenic substrate for determination 
of Gab by indirect immunofluorescence, to avoid 
unspecific reactions caused by bacterial or food 
antigens. Furthermore, it is important to u:se 
human tissue: antibodies, determined with rat 
colon (12, 40-42), do not correlate with Gab 
(9) and exhibit positive reactions also in C D 
and in healthy subjects. These 'heterophile' anti-
bodies often consist of IgM (42), in contrary to 
Aab against human goblet cells, which belonged 
only to the immunoglobulin classes IgC and 
IgA. 
The occurrence of Gab in UC has been dis-
cussed to be a corollary of an immunization 
against goblet cell antigens shedded from dama-
ged colonic mucosa and thus to be a secondary 
phenomenon (e.g. Ref. 6). But the strict absence 
of Gab in patients with CD of the colon is incon-
sistent with this explanation. On the other hand, 
one might also speculate that Pab result from a 
secondary immunization in the gut. This should 
take place in the small intestine, since high con-
centrated Pab essentially could not be detected in 
the colon-restricted UC. But significant Pab-titres 
also occurred in a number of patients with C D 
confined to the colon. Thus also the pancreas-
specific autoimmunity in CD seems to be a 
phenomenon of primary significance. 
Furthermore, a secondary immunization 
against pancreatic and goblet cell antigens would 
probably induce a polyclonal antibody response, 
and kappa and lambda light chains would be 
evenly distributed in each Pab or Gab. But the 
high frequency of antibodies with only one type 
of light-chain detectable gives evidence of an ol i-
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goclonal response: Both Pab and Gab are pro-
duced by a very small number of plasma cell 
clones. This result was confirmed with a higher 
n umber of sera (43) and might correspond to the 
finding of monoclonal lymphocyte populations in 
the peripheral blood of 12 out of 20 patients with 
C D or U C (44). The established oligoclonality of 
Pab and Gab speaks in favour of autoimmunity 
as being causatively involved in the aetiology of 
C D and UC. 
Pab and Gab seem to be disease-specific, and 
they do not yet indicate a disposition for CD or 
U C . This was shown by Döscher et al. (45) and 
Kosegarten et al. (46), who determined the preva-
lence of Pab and Gab in an up to now limited 
number of healthy appearing first-degree relatives 
of patients with C I B D . These persons carry an 
elevated risk for developing C I B D . One hundred 
and fourteen relatives of 46 UC patients and 71 
relatives of 52 CD patients did, however, not 
exhibit Pab or Gab in the sera in significant con-
centrations. Thus, subjects with a disposition for 
developing CD or UC obviously cannot be ident-
ified by determination of Pab and Gab. 
Diagnostic value of Pab and Gab: As with other 
autoimmune diseases, the cause of sensi t izat ion 
cannot yet be explained, either in CD or in UC, 
and further investigation is required to completely 
reveal the mystery of C I B D . But the knowledge 
of these autoimmune phenomena can be used 
with advantage for diagnostic purposes: High 
titres of Pab are specific markers of C D ; they 
cannot be observed in UC, coeliac disease, con-
trol persons, and not even in pancreatitis and 
subjects with a disposition for CD. On the other 
hand, Gab are exclusively present in patients with 
UC. In one third of cases with C I B D , the deter-
mination of Pab and Gab is sufficient to establish 
the diagnosis of CD or UC. 
The low frequency of Pab and Gab in C I B D 
should not give rise to scepticism about their 
implication in the pathogenesis of CD and UC: 
It is possible that Aab are neutralized by the 
corresponding circulating autoantigens or that 
patients without Aab only exhibit cellular 
immunoreactions. Or the occurrence of Aab is 
confined to the intestine in some patients. In 
most of the disorders with proven autoimmune 
aetiology, the corresponding disease-specific Aab 
do not reach a prevalence of 100% either. 
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